Immediate Impact
54 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Heterocyclic amino acids-based green and sustainable corrosion inhibitors: Adsorption, bonding and corrosion control
2024 Standout
Works of Luckson Mathieu being referenced
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Luckson Mathieu | 237 | 272 | 82 | 150 | 12 | 492 | |
| Qiuxia Dong | 191 | 314 | 70 | 127 | 14 | 495 | |
| Ann W. Gramza | 175 | 193 | 70 | 134 | 21 | 535 | |
| Yunhong Tian | 203 | 289 | 81 | 153 | 19 | 540 | |
| Israel Cañadas | 207 | 283 | 43 | 178 | 11 | 476 | |
| Rebecca Tay | 203 | 397 | 67 | 83 | 21 | 496 | |
| Tahsin M. Khan | 355 | 333 | 45 | 268 | 19 | 573 | |
| Andrea Ravelli | 246 | 284 | 35 | 198 | 15 | 533 | |
| Pranshu Bansal | 220 | 290 | 49 | 118 | 21 | 508 | |
| Xiaoling Ou | 395 | 271 | 91 | 178 | 12 | 550 | |
| Matthew Robson | 318 | 280 | 70 | 229 | 13 | 549 |
All Works
Login with ORCID to disown or claim papers
Loading papers...